Showing results (11-20 of 497) with videos related to
Sort By:
Pageof 50
Leukemia & Lymphoma|May 3, 2008
SNARK, a novel downstream molecule of EBV latent membrane protein 1, is associated with resistance to cancer cell deathJoo Hyun Kim, Won Seog Kim, Chaehwa ParkAsian Pacific Journal of Cancer Prevention : APJCP|May 29, 2025
Recent Advances and Challenges in Cancer Care, with a Focus on Multiple Myeloma, Lymphoma, and Lung Cancer: Key Insights from the Onco Summit 2024-The APAC ChapterJa Min Byun, Won Seog Kim, Myung-Ju AhnF1000Research|December 21, 2017
Recent advances in understanding and managing T-cell lymphomaJun Ho Yi, Seok Jin Kim, Won Seog KimThe Korean Journal of Internal Medicine|November 23, 2019
Asian variant of intravascular large B-cell lymphoma: a comparison of clinical features based on involvement of the central nervous systemSang Eun Yoon, Won Seog Kim, Seok Jin KimJournal of Hematology & Oncology|December 21, 2018
Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic reviewSeok Jin Kim, Sang Eun Yoon, Won Seog KimAnnals of Laboratory Medicine|January 11, 2024
Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid MalignanciesSeok Jin Kim, Sang Eun Yoon, Won Seog KimBlood Research|January 16, 2018
Brentuximab vedotin: clinical updates and practical guidanceJun Ho Yi, Seok Jin Kim, Won Seog KimFuture Oncology (London, England)|May 10, 2017
Looking to the future and learning lessons from the recent past: changing stakeholder perceptions of biosimilars in cancerWon Seog Kim, Michinori Ogura, Hyuk-Chan Kwon, et al.Cellular Signalling|July 31, 2010
Epstein-Barr virus latent membrane protein 1 increases chemo-resistance of cancer cells via cytoplasmic sequestration of Pim-1Joo Hyun Kim, Won Seog Kim, Yungdae Yun, et al.Current Opinion in Oncology|July 28, 2022
EBV-associated NK and T-cell lymphoid neoplasmsHiroshi Kimura, Laurence de Leval, Qingqing Cai, et al.Pageof 50